![]() |
|
|
Vol. 298, Issue 2, 718-728, August 2001
Canadian Institutes of Health Research Group in the Regulation of
Vascular Contractility and The Smooth Muscle Research Group, Department
of Pharmacology and Therapeutics, University of Calgary, Calgary,
Alberta, Canada
The effects of the cytochrome P450 inhibitors clotrimazole,
ketoconazole, and 1-aminobenzotriazole (1-ABT) on native delayed rectifier (KDR) and cloned Kv1.5 (RPV Kv1.5) K+
channels of rabbit portal vein (RPV) myocytes were determined using
whole-cell and single channel patch-clamp analysis. Clotrimazole reduced KDR and RPV Kv1.5 whole-cell current with
respective Kd values of 1.15 ± 0.39 and 1.99 ± 0.6 µM. Clotrimazole acted via an open state
blocking mechanism based on the following: 1) the early time course of
KDR current activation was not affected, but inhibition
developed with time during depolarizing steps and increased the rate of
decay in current amplitude; 2) the inhibition was voltage-dependent,
increasing steeply over the voltage range of KDR
activation; and 3) mean open time of RPV Kv1.5 channels in inside-out
patches was decreased significantly. Ketoconazole reduced
KDR current amplitude with a Kd
value of 38 ± 3.2 µM. However, ketoconazole acted via a closed
(resting) state blocking mechanism: 1) KDR amplitude was
reduced throughout the duration of depolarizing steps and the rate of
decay of current was unaffected, 2) there was no voltage dependence to
the block by ketoconazole over the KDR activation range,
and 3) ketoconazole did not affect mean open time of RPV Kv1.5 channels
in inside-out membrane patches. 1-ABT between 0.5 and 3 mM did not
affect native KDR or RPV Kv1.5 current of rabbit portal
vein myocytes. Clotrimazole and ketoconazole, but not 1-ABT, suppress
vascular KDR channels by direct, state-dependent block
mechanisms not involving the modulation of cytochrome P450 enzyme activity.
This article has been cited by other articles:
![]() |
H. Ouadid-Ahidouch, M. Roudbaraki, P. Delcourt, A. Ahidouch, N. Joury, and N. Prevarskaya Functional and molecular identification of intermediate-conductance Ca2+-activated K+ channels in breast cancer cells: association with cell cycle progression Am J Physiol Cell Physiol, July 1, 2004; 287(1): C125 - C134. [Abstract] [Full Text] [PDF] |
||||